BIOMAT Database Logo BIOMAT Database Logo

[Preliminary results of a cooperative clinical study of the new antitumor antibiotic, carminomycin]. 1976

V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia

The clinical trials of karminomycin, a new Soviet antitumor antibiotic in treatment of different malignant tumors showed that the drug had a pronounced antitumor activity against the soft tissue sarcomas of various histogenesis, lympho- and reticulosarcoma, acute leukemia and some other neoplasms.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002360 Carubicin A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata. Carminomycin,Karminomycin,Carminomicin,Carminomycin I,Carminomycin II,Carminomycin III,Carubicin Hydrochloride,Demethyldaunomycin,Demethyldaunorubicin,Karminomicin,NSC-180,024,NSC-180024,Rubeomycin A,Rubeomycin A1,Hydrochloride, Carubicin,NSC 180,024,NSC 180024,NSC180,024,NSC180024
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
A new antitumor antibiotic, carminomycin (NSC-180024).
January 1974, Cancer chemotherapy reports,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
Antitumor antibiotic carminomycin.
January 1980, Zeitschrift fur allgemeine Mikrobiologie,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[A study of the toxicity, pharmacokinetics and pharmacodynamics of the new antitumor antibiotic carminomycin].
January 1974, Antibiotiki,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[Results of a cooperative clinical study of the new antineoplastic antibiotic rubomycin].
December 1969, Antibiotiki,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[Results of cooperative clinical study of the new antineoplastic antibiotic, bruneomycin].
September 1968, Antibiotiki,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
Physical and chemical characteristics and structure of carminomycin, a new antitumor antibiotic.
April 1974, The Journal of antibiotics,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[Antitumor activity of carminomycin antibiotic used orally].
November 1976, Antibiotiki,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[The mechanism of the toxic effect of the antitumor antibiotic carminomycin].
January 1974, Antibiotiki,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[Results of a cooperative clinical study of the Russian antineoplastic antibiotic bleomycetin].
January 1988, Voprosy onkologii,
V I Borisov, and A M Lipatov, and N I Perevodchikova, and N A Alekseev, and Ia I Vygovskaia
[Study of the antitumor activity of carminomycin in malignant tumors in children (a preliminary report)].
July 1976, Antibiotiki,
Copied contents to your clipboard!